Heterozygous rare genetic variants in non-syndromic early-onset obesity.

Int J Obes (Lond) 2019 Mar 29. Epub 2019 Mar 29.

Hospital Infantil Universitario Niño Jesús, Department of Endocrinology, Instituto de Investigación La Princesa, Universidad Autónoma de Madrid, Department of Pediatrics, Avenida Menéndez Pelayo, 65, 28009, Madrid, Spain.

Background: Obesity is a very heterogeneous disorder at both the clinical and molecular levels and with high heritability. Several monogenic forms and genes with strong effects have been identified for non-syndromic severe obesity. Novel therapeutic interventions are in development for some genetic forms, emphasizing the importance of determining genetic contributions.

Objective: We aimed to define the contribution of rare single-nucleotide genetic variants (RSVs) in candidate genes to non-syndromic severe early-onset obesity (EOO; body mass index (BMI) >+3 standard deviation score, <3 years).

Methods: Using a pooled DNA-sequencing approach, we screened for RSVs in 15 obesity candidate genes in a series of 463 EOO patients and 480 controls. We also analysed exome data from 293 EOO patients from the "Viva la Familia" (VLF) study as a replication dataset.

Results: Likely or known pathogenic RSVs were identified in 23 patients (5.0%), with 7 of the 15 genes (BDNF, FTO, MC3R, MC4R, NEGR1, PPARG and SIM1) harbouring RSVs only in cases (3.67%) and none in controls. All were heterozygous changes, either de novo (one in BDNF) or inherited from obese parents (seven maternal, three paternal), and no individual carried more than one variant. Results were replicated in the VLF study, where 4.10% of probands carried RSVs in the overrepresented genes. RSVs in five genes were either absent (LEP) or more common in controls than in cases (ADRB3, LEPR, PCSK1 and PCSK2) in both obese datasets.

Conclusions: Heterozygous RSVs in several candidate genes of the melanocortin pathway are found in ~5.0% patients with EOO. These results support the clinical utility of genetic testing to identify patients who might benefit from targeted therapeutic intervention.

Download full-text PDF

http://dx.doi.org/10.1038/s41366-019-0357-5DOI Listing
March 2019
4 Reads

Publication Analysis

Top Keywords

early-onset obesity
non-syndromic severe
genetic variants
strong effects
effects identified
identified non-syndromic
body mass
variants rsvs
rare single-nucleotide
contributionsobjective aimed
heritability monogenic
monogenic forms
determining genetic
emphasizing determining
forms genes
genes strong
severe obesity
interventions development
genes non-syndromic
development genetic


(Supplied by CrossRef)

JM Friedman et al.
Nature 2000

AJ Walley et al.
Nat Rev Genet 2009

CH Llewellyn et al.
Int J Obes 2013

I Hatada et al.
Nat Genet 1996

GAacute Martos-Moreno et al.
Arch Dis Child 2014

RD Nicholls et al.
Lett Nat 1989

K Buiting et al.
Am J Hum Genet 2003

M Sanz-Fernández et al.
An Pediatr 2015

N Katsanis et al.
Science 2001

JC Han et al.
N Engl J Med 2008

S Ranadive et al.
Endocrinol Metab Clin North Am 2008

Similar Publications